Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lind

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
Postgraduate Medical Journal|October 1, 1990
Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant controlG Hall, M J Lind, M Huang, et al.
British Journal of Cancer|May 1, 1988
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee)D B Smith, M J Lind, S B Kaye, et al.
British Journal of Cancer|February 19, 2004
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisationH K Berrieman, J N E Ashman, M E Cowen, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Plasma and salivary pharmacokinetics of caffeine in manR Newton, L J Broughton, M J Lind, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative intraperitoneal pharmacokinetics of three platinum analoguesM J Lind, D J Murphy, H Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Cancer|January 1, 1988
Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour GroupN Thatcher, D B Smith, M J Lind, et al.
Journal of American College Health : J of ACH|December 1, 2020
Trauma exposure, alcohol consumption, and sleep quality: a latent growth curve modelS E Cusack, K E Bountress, M J Lind, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|June 1, 1989
The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivoM J Lind, A T McGown, J A Hadfield, et al.
Postgraduate Medical Journal|October 1, 1990
Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant controlG Hall, M J Lind, M Huang, et al.
British Journal of Cancer|May 1, 1988
A negative phase II trial methylene dimethane sulphonate in advanced ovarian cancer (Cancer Research Campaign Phase I/II Trials Committee)D B Smith, M J Lind, S B Kaye, et al.
British Journal of Cancer|February 19, 2004
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisationH K Berrieman, J N E Ashman, M E Cowen, et al.
European Journal of Clinical Pharmacology|January 1, 1981
Plasma and salivary pharmacokinetics of caffeine in manR Newton, L J Broughton, M J Lind, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Comparative intraperitoneal pharmacokinetics of three platinum analoguesM J Lind, D J Murphy, H Sharma, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinomaD Murphy, M J Lind, J Prendiville, et al.
Cancer|January 1, 1988
Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour GroupN Thatcher, D B Smith, M J Lind, et al.
Journal of American College Health : J of ACH|December 1, 2020
Trauma exposure, alcohol consumption, and sleep quality: a latent growth curve modelS E Cusack, K E Bountress, M J Lind, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisA G Kamthan, M J Lind, N Thatcher, et al.
Pageof 5